Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule

scientific article published on 30 May 2007

Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JAC/DKM147
P698PubMed publication ID17537868

P50authorStefan W. KrauseQ56915515
P2093author name stringErnst Holler
Reinhard Andreesen
Philipp Altmannsberger
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectamphotericin BQ412223
P304page(s)180-182
P577publication date2007-05-30
P1433published inJournal of Antimicrobial ChemotherapyQ6294770
P1476titleAmphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule
P478volume60

Reverse relations

cites work (P2860)
Q39211515Fungus ball in the urinary tract: A rare entity
Q37098160Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
Q28534551continuous versus conventional infusion of amphotericin B deoxycholate: a meta-analysis

Search more.